摘要
乳腺癌是全球女性最常见的恶性肿瘤,也是我国女性恶性肿瘤患者死亡的常见原因,严重危害女性的健康。目前,通过综合治疗手段的应用,乳腺癌已成为疗效较好的实体肿瘤之一。铂类药物在恶性肿瘤中应用广泛,是乳腺癌常用且有效的化疗药物之一。为规范铂类药物在乳腺癌治疗中的应用,中国医师协会肿瘤医师分会乳腺癌学组组织相关专家,在《铂类药物晚期乳腺癌应用专家共识(2020版)》基础上,根据国内外乳腺癌最新循证医学证据,对铂类药物在乳腺癌临床使用的适宜范围、应用方案、疗效分析及不良反应处理等方面进行充分讨论和更新,增加了铂类药物在早期乳腺癌临床使用的适宜范围、应用方案、疗效分析及不良反应处理等方面内容,制定《乳腺癌铂类药物临床应用专家共识(2023版)》,以指导临床医师合理用药,进一步规范诊疗行为。
Breast cancer is the most common malignant tumor in women around the world,and it is also a common cause of death in female patients with malignant tumors in China,which seriously harms women′s health.At present,with the application of comprehensive treatment approaches,breast cancer has become one of the most effective solid tumors.Platinum drugs are widely used in malignant tumors,and they are also commonly used as effective chemotherapeutic drugs for breast cancer.To regulate the application of platinum drugs in breast cancer,the experts from Breast Cancer Group,Branch of Oncologist,Chinese Medical Doctor Association,discuss and approve the"Guidelines for clinical application of platinum drugs in breast cancer(2023 edition)".This guideline is developed from the"Expert consensus on the clinical application of platinums in advanced breast cancer(2020 version)",which is updated from the latest evidence based on breast cancer at home and abroad,for platinum drugs in breast cancer clinical use,application scheme,efficacy analysis and treatment of adverse effects.This guideline aims to guide clinicians to use drugs rationally,and to further standardize the diagnosis and treatment.
作者
中国医师协会肿瘤医师分会乳腺癌学组
袁芃
徐兵河
Breast Cancer Group,Branch of Oncologist,Chinese Medical Doctor Association;Yuan Peng;Xu Binghe(不详;Department of Special Needs Medicine,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of Clinical Trials Center,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China)
出处
《中华肿瘤杂志》
CAS
CSCD
北大核心
2023年第12期1018-1031,共14页
Chinese Journal of Oncology
关键词
乳腺肿瘤
铂类药物
临床应用
专家共识
Breast neoplasms
Platinum drugs
Clinical applications
Expert consensus Contributor Information Breast Cancer Group,Branch of Oncologist,Chinese Medical Doctor Association
